Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.
Articles by Bionews Staff
Recent Posts
- Subset of immune T-cells may be therapeutic target in IgG4-RD
- US had over 50K cases of IGG4-RD as of 2024, disease statistics show
- Higher cancer risk possible with IgG4-RD diagnosis, report suggests
- Sinonasal involvement in IgG4-RD needs recognition: Review study
- Chest CT important for monitoring lung involvement in IgG4-RD: Study